Literature DB >> 15906351

Modulation of hepatic cytochromes P450 and phase II enzymes by dietary doses of sulforaphane in rats: Implications for its chemopreventive activity.

Victoria Yoxall1, Peter Kentish, Nick Coldham, Nikolai Kuhnert, Maurice J Sauer, Costas Ioannides.   

Abstract

The principal objectives of our study were to ascertain whether sulforaphane, at dietary levels of intake, modulates rat hepatic cytochrome P450 and phase II enzyme systems and to evaluate the impact of such changes in the chemopreventive activity of this isothiocyanate. Animals were exposed to sulforaphane in their drinking water for 10 days, equivalent to daily doses of 3 and 12 mg/kg. Depentylation of pentoxyresorufin decreased and was paralleled by a decline in CYP2B apoprotein levels. At the higher dose, erythromycin N-demethylase activity declined and was accompanied by a similar decrease in CYP3A2 apoprotein levels. However, sulforaphane treatment upregulated CYP1A2 levels, determined immunologically, but the dealkylations of methoxy- and ethoxyresorufin were not similarly increased. Hepatic S9 preparations from sulforaphane-treated rats were less effective than control preparations in converting IQ (2-amino-3-methylimidazo-[4,5-f]quinoline) to mutagenic intermediates in the Ames test. To clarify the underlying mechanism, in vitro studies were undertaken. In beta-naphthoflavone-treated rats, the inhibition by sulforaphane of the O-dealkylations of methoxy- and ethoxyresorufin was enhanced if the isothiocyanate was preincubated in the presence of NADPH. It may be inferred that sulforaphane induces hepatic CYP1A2 but the enzyme is not catalytically competent because of bound sulforaphane metabolite(s). Finally, sulforaphane stimulated, in a dose-dependent fashion, quinone reductase but failed to influence glutathione S-transferase, epoxide hydrolase and glucuronosyl transferase activities. It is concluded that, even at dietary doses, sulforaphane can modulate the xenobiotic-metabolising enzyme systems, shifting the balance of carcinogen metabolism toward deactivation, and this may be an important mechanism of its chemopreventive activity. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15906351     DOI: 10.1002/ijc.21191

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  Iberin induces cell cycle arrest and apoptosis in human neuroblastoma cells.

Authors:  Unmesh Jadhav; Ravesanker Ezhilarasan; Steven F Vaughn; Mark A Berhow; Sanjeeva Mohanam
Journal:  Int J Mol Med       Date:  2007-03       Impact factor: 4.101

2.  The role of Sulforaphane in cancer chemoprevention and health benefits: a mini-review.

Authors:  Reza Bayat Mokhtari; Narges Baluch; Tina S Homayouni; Evgeniya Morgatskaya; Sushil Kumar; Parandis Kazemi; Herman Yeger
Journal:  J Cell Commun Signal       Date:  2017-07-23       Impact factor: 5.782

3.  Pharmacokinetics of dietary cancer chemopreventive compound dibenzoylmethane in rats and the impact of nanoemulsion and genetic knockout of Nrf2 on its disposition.

Authors:  Wen Lin; Jin-Liern Hong; Guoxiang Shen; Rachel T Wu; Yuwen Wang; Mou-Tuan Huang; Harold L Newmark; Qingrong Huang; Tin Oo Khor; Tycho Heimbach; Ah-Ng Kong
Journal:  Biopharm Drug Dispos       Date:  2010-12-16       Impact factor: 1.627

4.  A glucosinolate-rich extract of Japanese Daikon perturbs carcinogen-metabolizing enzyme systems in rat, being a potent inducer of hepatic glutathione S-transferase.

Authors:  Ahmad Faizal Abdull Razis; Gina Rosalinda De Nicola; Eleonora Pagnotta; Renato Iori; Costas Ioannides
Journal:  Eur J Nutr       Date:  2012-06-19       Impact factor: 5.614

5.  Candidate dietary phytochemicals modulate expression of phase II enzymes GSTP1 and NQO1 in human lung cells.

Authors:  Xiang-Lin Tan; Miao Shi; Hui Tang; Weiguo Han; Simon D Spivack
Journal:  J Nutr       Date:  2010-06-16       Impact factor: 4.798

6.  Molecular Cloning, Expression and Characterisation of a Bacterial Myrosinase from Citrobacter Wye1.

Authors:  Fatma Cebeci; Melinda J Mayer; John T Rossiter; Richard Mithen; Arjan Narbad
Journal:  Protein J       Date:  2022-01-15       Impact factor: 2.371

7.  Sulforaphane attenuates the development of atherosclerosis and improves endothelial dysfunction in hypercholesterolemic rabbits.

Authors:  George S G Shehatou; Ghada M Suddek
Journal:  Exp Biol Med (Maywood)       Date:  2015-10-20

8.  ABC transporters and isothiocyanates: potential for pharmacokinetic diet-drug interactions.

Authors:  Urvi Telang; Yan Ji; Marilyn E Morris
Journal:  Biopharm Drug Dispos       Date:  2009-10       Impact factor: 1.627

Review 9.  Role of 4-hydroxynonenal in chemopreventive activities of sulforaphane.

Authors:  Rajendra Sharma; Abha Sharma; Pankaj Chaudhary; Mukesh Sahu; Shailesh Jaiswal; Sanjay Awasthi; Yogesh C Awasthi
Journal:  Free Radic Biol Med       Date:  2012-04-23       Impact factor: 7.376

Review 10.  GST polymorphism and excretion of heterocyclic aromatic amine and isothiocyanate metabolites after Brassica consumption.

Authors:  Susan E Steck; James R Hebert
Journal:  Environ Mol Mutagen       Date:  2009-04       Impact factor: 3.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.